1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 24th June 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Raynaud phenomenon: from GWAS to drug repurposing, 2024, Herrick et al

Discussion in 'Other health news and research' started by FMMM1, Jan 19, 2024.

Tags:
  1. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,761
    "Raynaud phenomenon: from GWAS to drug repurposing" - 2024

    "The identification of novel risk variants in the largest genome-wide association study of Raynaud phenomenon to date provides insights into the pathophysiology of the condition, including the potential role for α2A-adrenoceptors, and suggests opportunities for drug repurposing."

    Our hope is that the DecodeME will get us closer to that goal -

    Couldn't get access to full paper - https://www.nature.com/articles/s41...w GWAS included 5,147,: ADRA2A, IRX1 and MICB.
     
    FMMM1, Jan 19, 2024
    #1
    RedFox, Solstice, DokaGirl and 4 others like this.
  2. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    8,678
    Years ago I met someone who took antimalarial drugs for Raynaud phenomenon.
     
    Mij, Jan 20, 2024
    #2
    EndME and Solstice like this.

Share This Page